N-3-oxo-dodecanoyl-L-Homoserine lactone (Synonyms: 3-oxo-C12-HSL) |
| Katalog-Nr.GC17279 |
N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL), as a quorum-sensing (QS) molecule produced by Gram-negative bacteria in the gastrointestinal tract, is a major inducer of oxidative stress indicated by a high level of intracellular reactive oxygen species (ROS).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 168982-69-2
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL), as a quorum-sensing (QS) molecule produced by Gram-negative bacteria in the gastrointestinal tract, is a major inducer of oxidative stress indicated by a high level of intracellular reactive oxygen species (ROS)[1].
In vitro, 100μM 3-oxo-C12 HSL elevates intracellular free calcium in platelet, and 3-oxo-C12 HSL induces intracellular calcium-dependent ROS generation[2]. In vitro, 3-oxo-12-HSL also significantly inhibited LPS (lipopolysaccharides) induced IL-6 release at 10 μM, while 100 μM reduced IL-6 release by almost 75%[3]. In vitro, treatment of fibroblasts with 50 μM 3O-C12-HSL for 1 or 3 h (in contrast to 10 μM and the control) resulted in a rapid fragmentation of mitochondrial network, as evidenced by decreased mitochondrial length and area and an elevated number of small mitochondria[4]. In addition, 50 μM 3O-C12-HSL increases the cell area and protrusive activity of macrophages[5].
In vivo, Passively sensitized mice that had been treated with 3-oxo-12-HSL (3 mg/kg) 1 h prior to antigen exposure showed a significant (60%) decrease in PCA (passive cutaneous anaphylaxis) response[3].
References:
[1] Tao S, et al. Caspase-1-dependent mechanism mediating the harmful impacts of the quorum-sensing molecule N-(3-oxo-dodecanoyl)-l-homoserine lactone on the intestinal cells. J Cell Physiol. 2019 Apr;234(4):3621-3633.
[2] Yadav VK, et al. Pseudomonas aeruginosa quorum sensing molecule N-3-oxo-dodecanoyl-l-homoserine lactone activates human platelets through intracellular calcium-mediated ROS generation. Int J Med Microbiol. 2018 Oct;308(7):858-864.
[3] Khambati I, et al. The bacterial quorum-sensing molecule, N-3-oxo-dodecanoyl-L-homoserine lactone, inhibits mediator release and chemotaxis of murine mast cells. Inflamm Res. 2017 Mar;66(3):259-268.
[4] Josephson H, et al. Pseudomonas aeruginosa N-3-Oxo-Dodecanoyl-Homoserine Lactone Impacts Mitochondrial Networks Morphology, Energetics, and Proteome in Host Cells. Front Microbiol. 2020 May 25;11:1069.
[5]Holm A, et al. Pseudomonas aeruginosa N-3-oxo-dodecanoyl-homoserine Lactone Elicits Changes in Cell Volume, Morphology, and AQP9 Characteristics in Macrophages. Front Cell Infect Microbiol. 2016 Mar 24;6:32.
|
Cell experiment [1]: |
|
|
Cell lines |
Platelet cells |
|
Preparation method |
Platelet cells were incubated with 5 μM Fluo-4 AM for 45–50 min at 37 °C in the dark. After 60 s of baseline, 3-oxo-C12 HSL (100 μM), or DMSO as vehicle control were added in a different set of samples, and after 300 s 1 mM of CaCl2 was added, and fluorescence intensity was recorded up to 600 s. |
|
Reaction Conditions |
100 μM；300 s |
|
Applications |
3-oxo-C12 HSL induces intracellular calcium in a dose-dependent manner, and the maximum rise was obtained at 100 μM |
|
Animal experiment [2]: |
|
|
Animal models |
8 week-old C57BL/6 mice or in 6 week-old athymic nude mice |
|
Preparation method |
For C12 (N-3-oxo-dodecanoyl-L-Homoserine lactone) toxicity studies, DMSO or C12 (25 mg/kg/day) was administered intraperitoneally each day in 8 week-old C57BL/6 mice or in 6 week-old athymic nude mice. For wild-type A549 tumors, animals were treated with C12 for 6 times/week. For Bcl-2 over-expressing A549 cells tumors, DMSO or C12 was administered with C12 each day. For A549-control-shRNA and A549-PON2-shRNA tumors, DMSO or C12 was administered twice every three days. At the end of the experiments, tumors were excised for apoptosis evaluation. |
|
Dosage form |
25 mg/kg/day; i.p. |
|
Applications |
C12 inhibits lung tumor growth and induces tumor cell apoptosis in vivo. C12 inhibits LLC tumor growth and induces tumor cell apoptosis in vivo in a dose-dependent fashion. C12 induces tumor apoptotic cell death independent of anti-apoptotic Bcl-2 proteins. PON3 (lactonase paraoxonase) expression recovers C12 cytotoxicity in PON2-deficient tumor cells. |
|
References: [1] Yadav VK, et al. Mechanism underlying N-(3-oxo-dodecanoyl)-L-homoserine lactone mediated intracellular calcium mobilization in human platelets. Blood Cells Mol Dis. 2019 Nov;79:102340. [2] Zhao G, et al. N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins. Oncotarget. 2016 Feb 2;7(5):5924-42. |
|
| Cas No. | 168982-69-2 | SDF | |
| Überlieferungen | 3-oxo-C12-HSL | ||
| Chemical Name | 3-oxo-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-dodecanamide | ||
| Canonical SMILES | CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O | ||
| Formula | C16H27NO4 | M.Wt | 297.4 |
| Löslichkeit | ≤20mg/ml in DMSO;20mg/ml in dimethyl formamide | Storage | Store at -20°C, protect from light |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.3625 mL | 16.8124 mL | 33.6247 mL |
| 5 mM | 672.5 μL | 3.3625 mL | 6.7249 mL |
| 10 mM | 336.2 μL | 1.6812 mL | 3.3625 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *